U.S. flag

An official website of the United States government

NM_206937.2(LIG4):c.2305dup (p.Thr769fs) AND DNA ligase IV deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 26, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001043969.9

Allele description [Variation Report for NM_206937.2(LIG4):c.2305dup (p.Thr769fs)]

NM_206937.2(LIG4):c.2305dup (p.Thr769fs)

Gene:
LIG4:DNA ligase 4 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
13q33.3
Genomic location:
Preferred name:
NM_206937.2(LIG4):c.2305dup (p.Thr769fs)
HGVS:
  • NC_000013.11:g.108208964dup
  • NG_007396.1:g.11571dup
  • NM_001098268.2:c.2305dup
  • NM_001330595.2:c.2104dup
  • NM_001352598.2:c.2305dup
  • NM_001352599.2:c.2305dup
  • NM_001352600.2:c.2305dup
  • NM_001352601.2:c.2305dup
  • NM_001352602.2:c.2305dup
  • NM_001352603.1:c.2305dup
  • NM_001352604.2:c.2341dup
  • NM_001379095.1:c.2305dup
  • NM_002312.3:c.2305dup
  • NM_206937.2:c.2305dupMANE SELECT
  • NP_001091738.1:p.Thr769fs
  • NP_001317524.1:p.Thr702fs
  • NP_001339527.1:p.Thr769fs
  • NP_001339528.1:p.Thr769fs
  • NP_001339529.1:p.Thr769fs
  • NP_001339530.1:p.Thr769fs
  • NP_001339531.1:p.Thr769fs
  • NP_001339532.1:p.Thr769fs
  • NP_001339533.1:p.Thr781fs
  • NP_001366024.1:p.Thr769fs
  • NP_002303.2:p.Thr769fs
  • NP_996820.1:p.Thr769fs
  • LRG_79t1:c.2305dup
  • LRG_79:g.11571dup
  • LRG_79p1:p.Thr769fs
  • NC_000013.10:g.108861311_108861312insT
  • NC_000013.10:g.108861312dup
Protein change:
T702fs
Links:
dbSNP: rs1878251067
NCBI 1000 Genomes Browser:
rs1878251067
Molecular consequence:
  • NM_001098268.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001330595.2:c.2104dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352598.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352599.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352600.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352601.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352602.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352603.1:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352604.2:c.2341dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001379095.1:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_002312.3:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_206937.2:c.2305dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
DNA ligase IV deficiency
Synonyms:
Lig4 syndrome
Identifiers:
MONDO: MONDO:0011686; MedGen: C1847827; Orphanet: 99812; OMIM: 606593

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001207741Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 26, 2019)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency.

O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P.

Mol Cell. 2001 Dec;8(6):1175-85.

PubMed [citation]
PMID:
11779494

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001207741.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the LIG4 protein. Other variant(s) that disrupt this region (p.Arg814*) have been determined to be pathogenic (PMID: 11779494, 27063650, 15333585, 23337116, 24123394). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with LIG4-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the LIG4 gene (p.Thr769Asnfs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 143 amino acids of the LIG4 protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024